Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA214355 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Analysis of dexamethasone treated substrates during 3 hr in HeLa cell.
2015-02-22 | GSE49591 | GEO
Project description:Analysis of dexamethasone treated substrates during 3 hr in HeLa cell. Total RNA obtained from HeLa cells with treatement of dexamethasone during 3hr. The up- or down-regulated transcripts were compare to control (DMSO) treated HeLa cell RNA extract. Significant transcripts were confirmed by replication
2015-02-22 | E-GEOD-49591 | biostudies-arrayexpress
Project description:Genome-wide analysis of miRNA-targeted cellular NMD substrates in HeLa cell
| PRJNA117193 | ENA
Project description:Genome-wide analysis of Human Upf1, SMG5, SMG7 and PNRC2 downregulated substrates in HeLa cell
| PRJNA150109 | ENA
Project description:Genome-wide analysis of cellular NMD substrates that regulated by Upf1, PNRC2 or CTIF in HeLa cell
| PRJNA161531 | ENA
Project description:Genome-wide analysis of cellular SMD or NMD substrates that regulated by Upf1 or PNRC2 in HeLa cell
| PRJNA136279 | ENA
Project description:sgRNA library treated HeLa cell genome sequencing
| PRJNA307625 | ENA
Project description:Kynureninase is a member of a large family of catalytically diverse but structurally homologous pyridoxal 5'-phosphate (PLP) dependent enzymes known as the aspartate aminotransferase superfamily or alpha-family. The Homo sapiens and other eukaryotic constitutive kynureninases preferentially catalyze the hydrolytic cleavage of 3-hydroxy-l-kynurenine to produce 3-hydroxyanthranilate and l-alanine, while l-kynurenine is the substrate of many prokaryotic inducible kynureninases. The human enzyme was cloned with an N-terminal hexahistidine tag, expressed, and purified from a bacterial expression system using Ni metal ion affinity chromatography. Kinetic characterization of the recombinant enzyme reveals classic Michaelis-Menten behavior, with a Km of 28.3 +/- 1.9 microM and a specific activity of 1.75 micromol min-1 mg-1 for 3-hydroxy-dl-kynurenine. Crystals of recombinant kynureninase that diffracted to 2.0 A were obtained, and the atomic structure of the PLP-bound holoenzyme was determined by molecular replacement using the Pseudomonas fluorescens kynureninase structure (PDB entry 1qz9) as the phasing model. A structural superposition with the P. fluorescens kynureninase revealed that these two structures resemble the "open" and "closed" conformations of aspartate aminotransferase. The comparison illustrates the dynamic nature of these proteins' small domains and reveals a role for Arg-434 similar to its role in other AAT alpha-family members. Docking of 3-hydroxy-l-kynurenine into the human kynureninase active site suggests that Asn-333 and His-102 are involved in substrate binding and molecular discrimination between inducible and constitutive kynureninase substrates.
| S-EPMC2531291 | biostudies-literature
Project description:Dexamethasone-resistant multiple myeloma cell line OPM1 treated with Dexamethasone and/or DAC
| PRJNA111221 | ENA
Project description:Genome wide binding of glucocorticoid receptor in dexamethasone treated human monocyte derived macrophages
| PRJNA262586 | ENA